| scholarly article | Q13442814 |
| P2093 | author name string | Alan I Green | |
| Angela M Henricks | |||
| Jibran Y Khokhar | |||
| Wilder T Doucette | |||
| Lucas L Dwiel | |||
| P2860 | cites work | Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness | Q21090462 |
| Association Between Cannabis and Psychosis: Epidemiologic Evidence | Q22252342 | ||
| Cannabis Use and Earlier Onset of Psychosis | Q22253070 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Genome-wide meta-analyses identify multiple loci associated with smoking behavior | Q24597886 | ||
| High-potency cannabis and the risk of psychosis | Q24651025 | ||
| From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia | Q26744755 | ||
| Altered risk-based decision making following adolescent alcohol use results from an imbalance in reinforcement learning in rats | Q27302783 | ||
| The self-medication hypothesis of substance use disorders: a reconsideration and recent applications | Q28255574 | ||
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input | Q28301507 | ||
| A neurobiological basis for substance abuse comorbidity in schizophrenia | Q28347063 | ||
| Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses | Q28363062 | ||
| Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence | Q28531475 | ||
| Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome | Q30357827 | ||
| Adolescent intermittent ethanol exposure is associated with increased risky choice and decreased dopaminergic and cholinergic neuron markers in adult rats | Q30630790 | ||
| Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia | Q44743796 | ||
| Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions | Q44752429 | ||
| Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females | Q44900954 | ||
| Patterns of substance abuse in schizophrenia: nature and significance | Q44929899 | ||
| Early adolescent nicotine exposure affects later-life cocaine reward in mice. | Q45026067 | ||
| Animal modeling dual diagnosis schizophrenia: sensitization to cocaine in rats with neonatal ventral hippocampal lesions | Q45035938 | ||
| Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. | Q45988594 | ||
| Dysfunction of ventral striatal reward prediction in schizophrenia | Q46684383 | ||
| Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder | Q46857400 | ||
| Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program | Q47614680 | ||
| Adolescent nicotine exposure fails to impact cocaine reward, aversion and self-administration in adult male rats | Q47665990 | ||
| Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia. | Q47780196 | ||
| Alterations of the brain reward system in antipsychotic naïve schizophrenia patients | Q48002568 | ||
| Nicotine reverses hypofrontality in animal models of addiction and schizophrenia | Q48013467 | ||
| The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being | Q43708263 | ||
| Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients | Q43723165 | ||
| Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol | Q43957904 | ||
| Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon | Q44221615 | ||
| Escalation of drug use in early-onset cannabis users vs co-twin controls | Q44281651 | ||
| Neurophysiology of converging synaptic inputs from the rat prefrontal cortex, amygdala, midline thalamus, and hippocampal formation onto single neurons of the caudate/putamen and nucleus accumbens | Q44509867 | ||
| Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors | Q31116328 | ||
| Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? | Q33659891 | ||
| Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine | Q33703117 | ||
| Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey | Q33827207 | ||
| To model a psychiatric disorder in animals: schizophrenia as a reality test | Q33913794 | ||
| Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians | Q33925455 | ||
| Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats | Q33935945 | ||
| BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization | Q33945215 | ||
| A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs | Q33984901 | ||
| Striatal dopamine release in schizophrenia comorbid with substance dependence | Q34028727 | ||
| Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions | Q34063548 | ||
| Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study | Q34152985 | ||
| PKB/AKT: functional insights from genetic models | Q34389540 | ||
| Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 | ||
| Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective | Q34509505 | ||
| Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. | Q34514461 | ||
| Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats | Q34545094 | ||
| Lifetime prevalence of psychotic and bipolar I disorders in a general population | Q34596831 | ||
| Effects of ethanol exposure during adolescence or in adulthood on Pavlovian conditioned approach in Sprague-Dawley rats | Q34625520 | ||
| Binge ethanol exposure during adolescence leads to a persistent loss of neurogenesis in the dorsal and ventral hippocampus that is associated with impaired adult cognitive functioning | Q35077254 | ||
| Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study | Q35086108 | ||
| AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder | Q35356756 | ||
| A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia | Q35529636 | ||
| Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats | Q35624218 | ||
| Schizophrenia: diathesis-stress revisited | Q35898047 | ||
| Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia | Q36148521 | ||
| Cannabis abuse and risk for psychosis in a prodromal sample | Q36148531 | ||
| Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study | Q36296644 | ||
| The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia | Q36376582 | ||
| Insular and anterior cingulate circuits in smokers with schizophrenia. | Q36413030 | ||
| Effects of Emerging Alcohol and Marijuana Use Behaviors on Adolescents' Neuropsychological Functioning Over Four Years. | Q36467940 | ||
| Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait. | Q36529112 | ||
| Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend | Q36620997 | ||
| Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions | Q36652144 | ||
| Neural correlates of reward processing in schizophrenia--relationship to apathy and depression | Q48240864 | ||
| Salience network-midbrain dysconnectivity and blunted reward signals in schizophrenia | Q48298734 | ||
| Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions | Q48299239 | ||
| Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. | Q48444027 | ||
| A molecular basis for nicotine as a gateway drug | Q48452522 | ||
| BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia | Q48679191 | ||
| Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings | Q48812168 | ||
| Drug abuse in schizophrenic patients: clinical correlates and reasons for use. | Q48876065 | ||
| Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. | Q50458460 | ||
| Psychosis reactivity to cannabis use in daily life: an experience sampling study. | Q50689797 | ||
| Schizophrenia and co-occurring substance use disorder. | Q50695270 | ||
| Substance abuse and the onset of schizophrenia. | Q50990164 | ||
| Cannabis use at a young age is associated with psychotic experiences. | Q51650698 | ||
| Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. | Q51825628 | ||
| Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. | Q51914622 | ||
| Concurrent validation of schizotaxia: a pilot study. | Q51963486 | ||
| Review of integrated mental health and substance abuse treatment for patients with dual disorders. | Q51988911 | ||
| Cannabis dependence and psychotic symptoms in young people | Q52024293 | ||
| Treatment Cost and Rehospitalization Rate in Schizophrenic Outpatients With a History of Substance Abuse | Q52050154 | ||
| Expectations and motives for substance use in schizophrenia. | Q52212284 | ||
| Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. | Q52233655 | ||
| The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study. | Q52304306 | ||
| Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. | Q55056971 | ||
| Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users | Q57403275 | ||
| Smoking as a causal risk factor for schizophrenia | Q61822104 | ||
| The effects of cannabis use on the clinical condition of schizophrenics | Q70303444 | ||
| Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care | Q71158593 | ||
| Cannabis abuse and the course of recent-onset schizophrenic disorders | Q72371028 | ||
| Effect of patient and family insight on compliance of schizophrenic patients | Q73120843 | ||
| The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia | Q73967057 | ||
| Clozapine and substance abuse in patients with schizophrenia | Q77524704 | ||
| Adverse health effects of marijuana use | Q87672160 | ||
| Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. | Q36652502 | ||
| Adolescent intermittent ethanol exposure enhances ethanol activation of the nucleus accumbens while blunting the prefrontal cortex responses in adult rat. | Q36766437 | ||
| Adolescent Alcohol Exposure Amplifies the Incentive Value of Reward-Predictive Cues Through Potentiation of Phasic Dopamine Signaling. | Q36894444 | ||
| Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia | Q36947113 | ||
| Role of mTOR in physiology and pathology of the nervous system | Q36959417 | ||
| Lateral prefrontal model-based signatures are reduced in healthy individuals with high trait impulsivity | Q37058622 | ||
| Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia | Q37063606 | ||
| Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders | Q37075982 | ||
| Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers | Q37096565 | ||
| Use and abuse of alcohol and illicit drugs in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement. | Q37102918 | ||
| Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement | Q37172408 | ||
| Brain circuits that link schizophrenia to high risk of cigarette smoking | Q37228341 | ||
| Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population | Q37258886 | ||
| COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation | Q37284307 | ||
| The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia | Q37327529 | ||
| Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions | Q37565145 | ||
| Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. | Q37686545 | ||
| Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia | Q38144755 | ||
| Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls | Q38747159 | ||
| Consequences of adolescent use of alcohol and other drugs: Studies using rodent models | Q38916455 | ||
| Marijuana use in schizophrenia: a clear hazard | Q39211238 | ||
| Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia | Q39431580 | ||
| Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study | Q39680990 | ||
| Real-Time Electronic Ambulatory Monitoring of Substance Use and Symptom Expression in Schizophrenia | Q39958922 | ||
| Effect of Adolescent Cigarette Smoking on Adulthood Substance Use and Abuse: The Mediating Role of Educational Attainment. | Q40086147 | ||
| Genetic correlation between smoking behaviors and schizophrenia | Q40296328 | ||
| Cannabis use and risk of schizophrenia: a Mendelian randomization study. | Q40367490 | ||
| Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground | Q40424300 | ||
| Predictors of comorbid polysubstance use and mental health disorders in young adults-a latent class analysis. | Q40719457 | ||
| Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults. | Q40730801 | ||
| Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia | Q40879665 | ||
| Influence of cannabis abuse on schizophrenic psychopathology | Q41113315 | ||
| Rethinking the association between smoking and schizophrenia | Q41374798 | ||
| Cannabis and neuroleptic agents in schizophrenia | Q41535630 | ||
| Cortical-striatal gene expression in neonatal hippocampal lesion (NVHL)-amplified cocaine sensitization | Q42099889 | ||
| Effects of clozapine on smoking in chronic schizophrenic outpatients | Q42277362 | ||
| Modulation of dorsal thalamic cell activity by the ventral pallidum: its role in the regulation of thalamocortical activity by the basal ganglia | Q42488594 | ||
| Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia | Q42609446 | ||
| Dazed and confused by self-medication | Q42751868 | ||
| Substance use disorders in schizophrenia--clinical implications of comorbidity | Q43145195 | ||
| Gender difference in age at onset of schizophrenia: a meta-analysis | Q43673115 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substance use disorder | Q7632070 |
| schizophrenia | Q41112 | ||
| unifying hypothesis | Q108875272 | ||
| P577 | publication date | 2017-04-14 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | The link between schizophrenia and substance use disorder: A unifying hypothesis |
| Q92312184 | Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder |
| Q92212435 | Assessing the impacts of daily Cannabis versus alcohol and methamphetamines on young Australians in youth AOD treatment |
| Q90589681 | Binding of clozapine to the GABAB receptor: clinical and structural insights |
| Q94562591 | Childhood trauma and substance use underlying psychosis: a systematic review |
| Q88664573 | Drug use among youth: National survey data support a common liability of all drug use |
| Q99566199 | EXTENDED ATTENUATION OF CORTICOSTRIATAL POWER AND COHERENCE AFTER ACUTE EXPOSURE TO VAPOURIZED Δ9 TETRAHYDROCANNABINOL IN RATS |
| Q89804908 | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database |
| Q88687361 | Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability |
| Q94544886 | Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders |
| Q97644343 | Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting |
| Q90092071 | Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges |
| Q92141044 | Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS) |
| Q89723703 | The Risk of Sexually Transmitted Infections Following First-Episode Schizophrenia Among Adolescents and Young Adults: A Cohort Study of 220 545 Subjects |
| Q50138280 | Unique Effects of Clozapine: A Pharmacological Perspective |
Search more.